Satish R Raj Selected Research

Midodrine (Midon)

1/2022	Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis.
10/2021	Midodrine for the Prevention of Vasovagal Syncope : A Randomized Clinical Trial.
12/2020	Frequency of injuries associated with syncope in the prevention of syncope trials.
2/2020	Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension.
6/2019	Neglected cause of recurrent syncope: a case report of neurogenic orthostatic hypotension.
1/2018	Orthostatic hypotension for the cardiologist.
1/2016	Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine.
12/2014	Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
12/2012	Rationale for the prevention of syncope trial IV: assessment of midodrine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satish R Raj Research Topics

Disease

24	Postural Orthostatic Tachycardia Syndrome 08/2022 - 04/2005
21	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 03/2006
16	Syncope (Fainting) 01/2022 - 06/2006
12	Vasovagal Syncope 06/2022 - 12/2012
12	Tachycardia (Tachyarrhythmias) 12/2021 - 05/2005
10	Hypertension (High Blood Pressure) 01/2019 - 03/2006
5	Hypovolemia 01/2021 - 04/2005
4	Bradycardia 01/2020 - 10/2010
3	Hypotension (Low Blood Pressure) 10/2021 - 08/2005
3	Insulin Resistance 01/2017 - 10/2014
3	Heart Failure 01/2017 - 10/2002
2	Critical Illness (Critically Ill) 01/2022 - 04/2010
2	Hyperventilation 01/2021 - 01/2012
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 08/2017
2	Autonomic Nervous System Diseases (Dysautonomia) 01/2020 - 01/2020
2	Obesity 12/2015 - 10/2014
2	Atrial Fibrillation 11/2003 - 03/2003
1	Chronic Renal Insufficiency 01/2022
1	Brain Hypoxia (Cerebral Hypoxia) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Infections 01/2021
1	Familial Dysautonomia (Riley Day Syndrome) 01/2021
1	Sinus Arrhythmia 01/2021
1	Orthostatic Intolerance 11/2020
1	Disease Progression 11/2020
1	Shock 11/2020
1	Pain (Aches) 10/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2017
1	Multiple System Atrophy 08/2017
1	Dementia (Dementias) 08/2017
1	Diabetic Neuropathies (Diabetic Neuropathy) 08/2017
1	Pure Autonomic Failure 08/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Diabetes Mellitus 01/2017

Drug/Important Bio-Agent (IBA)

12	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 06/2008
9	Midodrine (Midon)FDA LinkGeneric 01/2022 - 12/2012
8	Pharmaceutical PreparationsIBA 01/2021 - 03/2003
7	ReninIBA 01/2018 - 04/2005
6	FludrocortisoneIBA 01/2021 - 06/2006
6	hydroxide ionIBA 11/2020 - 08/2006
5	AutoantibodiesIBA 08/2022 - 02/2014
5	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 11/2019 - 07/2007
5	AngiotensinsIBA 01/2018 - 03/2011
4	SodiumIBA 01/2021 - 08/2006
4	AldosteroneIBA 02/2016 - 04/2005
3	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2021 - 11/2010
3	DroxidopaIBA 02/2020 - 01/2018
3	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 09/2009
3	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2020 - 07/2007
3	Adrenergic Agents (Adrenergic Drugs)IBA 12/2019 - 01/2017
3	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2019 - 12/2014
3	Angiotensin IIIBA 02/2016 - 02/2012
2	SaltsIBA 01/2021 - 01/2021
2	Vasoconstrictor AgentsIBA 01/2021 - 12/2014
2	VaccinesIBA 01/2020 - 01/2020
2	LigandsIBA 01/2018 - 01/2014
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 03/2011
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2017 - 03/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 10/2015
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2017 - 03/2011
2	MineralocorticoidsIBA 02/2016 - 03/2008
2	Insulin (Novolin)FDA Link 10/2015 - 10/2014
2	Sildenafil Citrate (Viagra)FDA Link 12/2014 - 06/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2014 - 02/2013
2	Neurotransmitter Agents (Neurotransmitter)IBA 02/2014 - 03/2011
2	Caffeine (No Doz)FDA LinkGeneric 01/2014 - 03/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2022
1	Hormones (Hormone)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 12/2021
1	Ion Channels (Ion Channel)IBA 11/2021
1	Cholinergic ReceptorsIBA 08/2021
1	AntibodiesIBA 08/2021
1	Domperidone (Domperidon)IBA 01/2021
1	Dietary SodiumIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	CatecholaminesIBA 01/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2019
1	Procaine (Novocaine)FDA LinkGeneric 10/2019
1	Carticaine (Articaine)IBA 10/2019
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 10/2019
1	Local AnestheticsIBA 10/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2019
1	Mepivacaine (Carbocaine)FDA LinkGeneric 10/2019
1	empagliflozinIBA 01/2019
1	SilverIBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	ProdrugsIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Type 1 Angiotensin ReceptorIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 08/2017

Therapy/Procedure

13	Therapeutics 06/2022 - 04/2006
2	Drug Therapy (Chemotherapy) 12/2018 - 03/2010
1	Electric Countershock (Cardioversion) 12/2021
1	Aftercare (After-Treatment) 01/2021
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2020
1	Heart Transplantation (Grafting, Heart) 01/2017